Analysis of Sciellin (SCEL) as a candidate gene in esophageal squamous cell carcinoma

Anticancer Res. 2004 May-Jun;24(3a):1417-9.

Abstract

Background: The aim of this study was to investigate whether a candidate gene, Sciellin (SCEL), mapping to the chromosome 13q21-q31 is mutated in esophageal cancer.

Materials and methods: The coding region and intron-exon junctions of SCEL were sequenced in 13 esophageal squamous cell cancers and matching normal esophageal samples to detect mutations.

Results: Three single nucleotide polymorphisms were detected in SCEL of which two were silent mutations (L640L and H654H) and one missense mutation (R366K).

Conclusion: Single nucleotide polymorphisms were detected in both matching tumor and normal esophageal tissues but no disease-associated mutations suggesting that SCEL is not a major factor in esophageal squamous cell carcinogenesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carcinoma, Squamous Cell / genetics*
  • Carrier Proteins / genetics*
  • Esophageal Neoplasms / genetics*
  • Esophageal Neoplasms / pathology
  • Exons
  • Humans
  • Introns
  • Mutation
  • Neoplasm Staging
  • Polymorphism, Single Nucleotide

Substances

  • Carrier Proteins
  • SCEL protein, human